Efficacy of bromocriptine versus breast binders as inhibitors of postpartum lactation

A. G. Shapiro, L. Thomas

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Fifty postpartum patients were randomly given either bromocriptine (2.5 mg by mouth b.i.d. x 30 doses) or breast binders for inhibiting lactation. The breast binder group had a high incidence of symptoms (breast pain, engorgement, secretion) for the first week postpartum; these symptoms rapidly decreased by the second week. Bromocriptine successfully suppressed the breast problems in virtually all of the patients who took the drug correctly. Because of the high rate of side effects and a significant incidence of 'rebound', the dosage of bromocriptine should probably be changed, and we recommend a revised dosage.

Original languageEnglish
Pages (from-to)719-721
Number of pages3
JournalSouthern Medical Journal
Volume77
Issue number6
StatePublished - Jan 1 1984
Externally publishedYes

Fingerprint

Bromocriptine
Lactation
Postpartum Period
Breast
Mastodynia
Incidence
Mouth
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Efficacy of bromocriptine versus breast binders as inhibitors of postpartum lactation. / Shapiro, A. G.; Thomas, L.

In: Southern Medical Journal, Vol. 77, No. 6, 01.01.1984, p. 719-721.

Research output: Contribution to journalArticle

Shapiro, A. G. ; Thomas, L. / Efficacy of bromocriptine versus breast binders as inhibitors of postpartum lactation. In: Southern Medical Journal. 1984 ; Vol. 77, No. 6. pp. 719-721.
@article{b3ec9f231332498aa5a23ae5736212d8,
title = "Efficacy of bromocriptine versus breast binders as inhibitors of postpartum lactation",
abstract = "Fifty postpartum patients were randomly given either bromocriptine (2.5 mg by mouth b.i.d. x 30 doses) or breast binders for inhibiting lactation. The breast binder group had a high incidence of symptoms (breast pain, engorgement, secretion) for the first week postpartum; these symptoms rapidly decreased by the second week. Bromocriptine successfully suppressed the breast problems in virtually all of the patients who took the drug correctly. Because of the high rate of side effects and a significant incidence of 'rebound', the dosage of bromocriptine should probably be changed, and we recommend a revised dosage.",
author = "Shapiro, {A. G.} and L. Thomas",
year = "1984",
month = "1",
day = "1",
language = "English",
volume = "77",
pages = "719--721",
journal = "Southern Medical Journal",
issn = "0038-4348",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Efficacy of bromocriptine versus breast binders as inhibitors of postpartum lactation

AU - Shapiro, A. G.

AU - Thomas, L.

PY - 1984/1/1

Y1 - 1984/1/1

N2 - Fifty postpartum patients were randomly given either bromocriptine (2.5 mg by mouth b.i.d. x 30 doses) or breast binders for inhibiting lactation. The breast binder group had a high incidence of symptoms (breast pain, engorgement, secretion) for the first week postpartum; these symptoms rapidly decreased by the second week. Bromocriptine successfully suppressed the breast problems in virtually all of the patients who took the drug correctly. Because of the high rate of side effects and a significant incidence of 'rebound', the dosage of bromocriptine should probably be changed, and we recommend a revised dosage.

AB - Fifty postpartum patients were randomly given either bromocriptine (2.5 mg by mouth b.i.d. x 30 doses) or breast binders for inhibiting lactation. The breast binder group had a high incidence of symptoms (breast pain, engorgement, secretion) for the first week postpartum; these symptoms rapidly decreased by the second week. Bromocriptine successfully suppressed the breast problems in virtually all of the patients who took the drug correctly. Because of the high rate of side effects and a significant incidence of 'rebound', the dosage of bromocriptine should probably be changed, and we recommend a revised dosage.

UR - http://www.scopus.com/inward/record.url?scp=0021274355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021274355&partnerID=8YFLogxK

M3 - Article

C2 - 6729548

AN - SCOPUS:0021274355

VL - 77

SP - 719

EP - 721

JO - Southern Medical Journal

JF - Southern Medical Journal

SN - 0038-4348

IS - 6

ER -